Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,146.1
-34.9 (-1.10%)

 

  • STI Straits Times Index
    3,146.1
    -34.9 (-1.10%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,490.4
    -40.8 (-2.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,872.8
    -436.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,031.2
    -8.4 (-0.28%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,386.7
    -92.4 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,799.5
    -82.7 (-1.41%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 888.0M
  • Value: 1,070.3M
  • Rise: 46
  • Fall: 306
  • Unch: 462

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AusGroup^0.044-0.004
Rex Intl0.181-0.012
Medtecs Intl0.097-
Golden Agri-Res0.205-0.010
YZJ Shipbldg SGD1.000-0.040
ThaiBev0.820-0.025
Singtel3.120+0.020
Broadway Ind^0.077-0.023
OEL0.026-0.002
Kep Infra Tr0.535-0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,576.6 -174.4
HSI 26,841.7 -467.1
HSCEI 10,578.5 -212.3
Jakarta 5,795.8 -86.4
Nikkei 225 23,386.7 -92.4
SSE Comp 3,031.2 -8.4
Shanghai A 3,176.5 -8.8
Shanghai B 244.5 -0.4
KOSPI 2,079.0 -83.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NEXT SCIENCE LTD NEXT SCIENCE
Updated on 21 Feb 2020 (End of trading day)
Last (AUD): 1.935 Change: -0.065 High: 1.990 Remarks: -
Change (%): -3.25 Low: 1.930
Open 1.990 Yesterday's Close 2.0
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 95,864 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.10225 Trailing EPS (AUD) e -0.10225 NAV (AUD) b 0.1932
PE a - Trailing PE f - Price / NAV b 10.0155
Dividend (AUD) d - Cash In Hand (AUD) g 0.1819 Issued & Paid-up Shares c 180,060,000
Dividend Yield (%) d - Price / Cash In Hand g 10.638 Treasury Shares h -
Beta - 75 Daysi 0.903 R-Squared - 75 Days(%)i 2.22 Market Cap (M) 348.416
Beta - 500 Daysi 1.144 R-Squared - 500 Days (%)i 0.04 Enterprise Value (M) 316.487
Piotroski F Score 3 Exchange Code NXS Par Value ( AUD ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 43.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 20 Dec 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 18 Apr 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NEXT SCIENCE LTD ASX 348.416 - - 10.0155 -
Industry Biotechnology ASX 3,999.579 68.389 62.119 138.6023 0.753
Local Peer CSL ASX 152,685.905 56.910 52.709 - 0.789
Local Peer POLYNOVO LIMITED ASX 2,042.762 - - 78.2278 -
Local Peer AVITA MEDICAL LTD ASX 1,619.865 - - 13.0769 -
Local Peer MESOBLAST LTD ASX 1,467.466 - - 2.0830 -
Local Peer TELIX PHARMACEUTIC ASX 405.512 - - 9.3897 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 282.686 91.977 - 16.8512 -
Local Peer IMMUTEP LTD ASX 162.527 - - - -
Local Peer IMUGENE LIMITED ASX 150.483 - - 5.4839 -
Local Peer CYNATA THERAPEUTICS LTD ASX 111.259 - - 11.4286 -
Local Peer BIOTRON ASX 77.213 - - 14.2857 -
Local Peer INVEX THERAPEUTICS LTD NPV ASX 64.075 - - - -
Local Peer HOLISTA COLLTECH LIMITED ASX 50.393 - - 9.6059 -
Other Local Peers MEMPHASYS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), BIONOMICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), ADALTA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LEAF RESOURCES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CRYOSITE (ASX)
Global Peer AMGEN INC NASDAQ 131,403.102 15.654 16.756 13.5845 2.530
Global Peer GILEAD SCIENCES INC NASDAQ 88,240.200 16.176 16.383 3.8958 3.313
Global Peer AMGEN-T HKEx 589,807.000 8.965 9.598 7.8255 4.417
Global Peer VERTEX PHARMACEUTICAL NASDAQ 63,855.362 30.460 54.261 10.4935 -
Global Peer BIOGEN INC NASDAQ 58,609.089 13.228 9.953 4.3924 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 44,354.551 18.145 20.963 3.9996 -
Global Peer ILLUMINA INC NASDAQ 43,503.180 52.667 43.416 9.4305 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 26,437.034 83.661 34.603 5.4532 0.717
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,835.299 294.265 9.498 2.0259 -
Global Peer SEATTLE GENETICS INC NASDAQ 20,154.420 - - 10.7416 -
Other Global Peers WUXI BIO (HKEx), SINO BIOPHARM (HKEx), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), Lonza (SGX), GENSCRIPT BIO (HKEx), MIRATI THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), 3SBIO (HKEx), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ALKERMES PLC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALPHAMAB-B (HKEx), EPIZYME INC (NASDAQ), VIELA BIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), ARVINAS INC (NASDAQ), REGENXBIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CORTEXYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), HAOHAI BIOTEC (HKEx), TG THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NEXTCURE INC (NASDAQ), FRONTAGE (HKEx), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), DERMIRA INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), AVROBIO INC (NASDAQ), KADMON HLDGS INC (NYSE), CARA THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), MOLECULAR TEMPLATES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PRECIGEN INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), RETROPHIN INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), BIOXCEL THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ARDELYX INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), COMPUGEN (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), XBIOTECH INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ASCLETIS-B (HKEx), NANTKWEST INC (NASDAQ), MACROGENICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SINOMAB BIO-B (HKEx), AGENUS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), PROTHENA CORP PLC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), RECRO PHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), LEE'S PHARM (HKEx), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PFENEX INC (NYSE American), UNITY BIOTECHNOLOGY INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), KAMADA (NASDAQ), SERES THERAPEUTICS (NASDAQ), DPHARMA (Bursa), VBI VACCINES INC CDA (NASDAQ), GERON CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), XOMA CORP (NASDAQ), BBI LIFE SCI (HKEx), LIMINAL BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), MEDICINOVA INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), PIERIS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIASMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), VERASTEM INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CEL-SCI CORP (NYSE American), SOLID BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ARAVIVE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), UNI-BIO GROUP (HKEx), AVALON GLOBOCARE CORP (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), SAVARA INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), OTONOMY INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), CHIMERIX INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), VERMILLION INC (NASDAQ), SYNLOGIC INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), VACCINEX INC (NASDAQ), EQUILLIUM INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), ORGENESIS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), LEAP THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), INMUNE BIO INC (NASDAQ), RESTORBIO INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CT ENTERPRISE (HKEx), OPIANT PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VAXART INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ZAFGEN INC (NASDAQ), CURIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), TOCAGEN INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), EVOGENE LTD (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), SEELOS THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ORAGENICS INC (NYSE American), BIOCARDIA INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), IBIO INC (NYSE American), REGENT PACIFIC (HKEx), OCUGEN INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), CELLECTAR BIOSCIENCES INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), Suntar Eco-City^ (SGX), CYCLACEL PHARMA IN (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), SENECA BIOPHARMA INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), HAO WEN HLDGS (HKEx), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PHIO PHARMACEUTICALS CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.235
-10.83 %
10 Days --0.535
-21.66 %
20 Days --0.315
-14.00 %
Medium Term Return 3 Months --0.575
-22.91 %
6 Months --0.835
-30.14 %
1 Year -+1.780
+1148.39 %
Long Term Return 2 Years -+1.780
+1148.39 %
3 Years -+1.780
+1148.39 %
5 Years -+1.780
+1148.39 %
Annualised Return Annualised --
+65.68 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.240 - 4.730 Change From 1 Year Low +0.695 % Change From 1 Year Low (%) +56.05
Change From 1 Year High -2.795 % Change From 1 Year High (%) -59.09
2 Years Range 1.240 - 4.730 Change From 2 Years Low +0.695 % Change From 2 Years Low (%) +56.05
Change From 2 Years High -2.795 % Change From 2 Years High (%) -59.09
5 Years Range 1.240 - 4.730 Change From 5 Years Low +0.695 % Change From 5 Years Low (%) +56.05
Change From 5 Years High -2.795 % Change From 5 Years High (%) -59.09
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. It commercialize proprietary Xbio technology to reduce the impact of biofilm based infections in human health. The company was founded by Matthew Myntti on October 20, 2017 and is headquartered in Chatswood, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Feb 2020 1.990 1.990 1.930 1.935 95,864 -
20 Feb 2020 2.000 2.010 1.900 2.000 142,739 -
19 Feb 2020 2.050 2.070 1.975 1.980 194,545 -
18 Feb 2020 2.040 2.100 2.010 2.020 125,653 -
17 Feb 2020 2.180 2.180 2.060 2.080 136,594 -
14 Feb 2020 2.220 2.250 2.110 2.170 149,604 -
13 Feb 2020 2.300 2.300 2.175 2.240 195,154 -
12 Feb 2020 2.240 2.390 2.240 2.280 66,543 -
11 Feb 2020 2.320 2.320 2.200 2.240 77,635 -
10 Feb 2020 2.470 2.480 2.340 2.340 66,142 -
07 Feb 2020 2.490 2.490 2.350 2.470 115,274 -
06 Feb 2020 2.480 2.510 2.430 2.490 118,941 -
05 Feb 2020 2.510 2.580 2.460 2.480 57,841 -
04 Feb 2020 2.550 2.570 2.370 2.460 168,570 -
03 Feb 2020 2.700 2.700 2.480 2.550 200,135 -
31 Jan 2020 2.400 2.760 2.400 2.690 297,156 -
30 Jan 2020 2.360 2.390 2.320 2.390 109,226 -
29 Jan 2020 2.240 2.330 2.100 2.330 172,998 -
28 Jan 2020 2.290 2.290 2.150 2.240 58,664 -
24 Jan 2020 2.290 2.300 2.200 2.250 100,050 -
23 Jan 2020 2.270 2.330 2.220 2.240 91,708 -
22 Jan 2020 2.260 2.360 2.250 2.260 31,157 -
Summary
Current 2 Weeks
(10 Feb 2020 to 21 Feb 2020)
2.470 2.480 1.900 1.935 1,250,473 -
Previous 2 Weeks
(24 Jan 2020 to 07 Feb 2020)
2.290 2.480 1.900 2.470 1,398,855 -
4 Weeks from
(24 Dec 2019 to 23 Jan 2020)
1.850 2.480 1.840 2.240 2,329,381 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.